Tag: Biopharma
Hansa Biopharma to host conference call to provide half year results...
LUND, Sweden, July 6, 2023 /PRNewswire/ -- Hansa Biopharma AB (Nasdaq Stockholm: HNSA) will publish its interim report for January-June 2023 at 8:00...
CENTOGENE and Lifera, a Biopharma Company Owned by the PIF, Enter...
Joint Venture (JV) combines CENTOGENE's global leadership in multiomics with local insight of Lifera, a biopharmaceutical company wholly-owned by the Public Investment Fund...
Day One Announces Pricing of Public Offering of Common Stock –...
BRISBANE, Calif., June 06, 2023 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. DAWN, a clinical-stage biopharmaceutical company dedicated to developing and...
Landos Biopharma Announces 1-for-10 Reverse Stock Split – Landos Biopharma (NASD…...
NEW YORK, May 25, 2023 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. LABP, a clinical-stage biopharmaceutical company developing novel, oral medicines for...
POINT Biopharma Makes Strategic Investment in Commercial-Scale Alpha-Emitting Is… – Press...
INDIANAPOLIS and LANSING, Mich., May 15, 2023 (GLOBE NEWSWIRE) -- POINT Biopharma Global Inc. PNT (the "Company" or "POINT"), a company...
Sobi to acquire CTI BioPharma Corp. enhancing Sobi’s position in rare...
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE...
Nexcella, an Immix Biopharma subsidiary, Announces Positive 58-Patient NXC-201 C… –...
Multiple Myeloma92% was the overall response rate produced by NXC-201 in relapsed/refractory multiple myeloma patients treated at the therapeutic dose of 800 million...
Automation in Biopharma Industry Market is Projected to Grow at a...
Visiongain has published a new report entitled Automation in Biopharma Industry 2023-2033. Forecasts by Technology (Automation Technology, Digitization Technology), by Application (Clinical Phase, Drug Discovery...
AEON Biopharma Confirms Development Strategy and Timelines for ABP-450 Unaffecte… –...
IRVINE, Calif., Feb. 10, 2023 (GLOBE NEWSWIRE) -- AEON Biopharma, Inc. ("AEON" or the "Company"), a clinical-stage biopharmaceutical company focused on...
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in...
YONGIN, South Korea, Feb. 8, 2023 /PRNewswire/ -- GC Biopharma (006280.KS), a leading provider of biopharmaceutical products in South Korea, announced today that...